Live
- Woman’s False Claim Sparks Unnecessary Panic
- Locals Report Naxal Activity in Karkala Village
- Mangaluru International Airport Sets New Records in Passenger and Flight Movements
- Where Areca failed, grow Coffee
- Collector Badavath Santosh Reviews Household Survey and Listing Process
- Awareness Session on SHE Team and POCSO Act
- Awareness Program in agricultural College on the Dangers of Drug Abuse for Youth
- 3500-Year-Old Menhir in Kamsanpally Village: A Call for Preservation
- The Role of Artificial Intelligence in Radiology: Transforming Diagnosis and Patient Care
- Hindustan Zinc Ltd. Signs MoU with Rajasthan Government to Invest Rs 36 Crores in Education Development
300 million doses of Covid vaccine ready by Dec: Serum Institute of India
Adar Poonawalla of the Serum Institute of India (SII) has said at least 300 million doses of the potential coronavirus vaccine will be made available by December
New Delhi: Adar Poonawalla of the Serum Institute of India (SII) has said at least 300 million doses of the potential coronavirus vaccine will be made available by December.
With the trials of Covid-19 vaccine being developed by AstraZeneca and Oxford University showing encouraging results, Adar Poonawalla of the Serum Institute of India (SII) has said at least 300 million doses of the potential vaccine will be ready by December.
In an interview to India Today, Poonawalla said, "Each dose has 10 vials and Covishield is going to be the first Covid-19 vaccine we hope to launch if trials are successful in the UK and India."
He said that they expect the vaccine to reach the people of India in large numbers by the first quarter of 2021. The vaccine will cost around Rs 1,000 in India, he added.
